Cargando…

A longitudinal model for disease progression was developed and applied to multiple sclerosis

OBJECTIVES: To develop a model of disease progression using multiple sclerosis (MS) as an exemplar. STUDY DESIGN AND SETTINGS: Two observational cohorts, the University of Wales MS (UoWMS), UK (1976), and British Columbia MS (BCMS) database, Canada (1980), with longitudinal disability data [the Expa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawton, Michael, Tilling, Kate, Robertson, Neil, Tremlett, Helen, Zhu, Feng, Harding, Katharine, Oger, Joel, Ben-Shlomo, Yoav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643305/
https://www.ncbi.nlm.nih.gov/pubmed/26071892
http://dx.doi.org/10.1016/j.jclinepi.2015.05.003
_version_ 1782400502583001088
author Lawton, Michael
Tilling, Kate
Robertson, Neil
Tremlett, Helen
Zhu, Feng
Harding, Katharine
Oger, Joel
Ben-Shlomo, Yoav
author_facet Lawton, Michael
Tilling, Kate
Robertson, Neil
Tremlett, Helen
Zhu, Feng
Harding, Katharine
Oger, Joel
Ben-Shlomo, Yoav
author_sort Lawton, Michael
collection PubMed
description OBJECTIVES: To develop a model of disease progression using multiple sclerosis (MS) as an exemplar. STUDY DESIGN AND SETTINGS: Two observational cohorts, the University of Wales MS (UoWMS), UK (1976), and British Columbia MS (BCMS) database, Canada (1980), with longitudinal disability data [the Expanded Disability Status Scale (EDSS)] were used; individuals potentially eligible for MS disease-modifying drugs treatments, but who were unexposed, were selected. Multilevel modeling was used to estimate the EDSS trajectory over time in one data set and validated in the other; challenges addressed included the choice and function of time axis, complex observation-level variation, adjustments for MS relapses, and autocorrelation. RESULTS: The best-fitting model for the UoWMS cohort (404 individuals, and 2,290 EDSS observations) included a nonlinear function of time since onset. Measurement error decreased over time and ad hoc methods reduced autocorrelation and the effect of relapse. Replication within the BCMS cohort (978 individuals and 7,335 EDSS observations) led to a model with similar time (years) coefficients, time [0.22 (95% confidence interval {CI}: 0.19, 0.26), 0.16 (95% CI: 0.10, 0.22)] and log time [−0.13 (95% CI: −0.39, 0.14), −0.15 (95% CI: −0.70, 0.40)] for BCMS and UoWMS, respectively. CONCLUSION: It is possible to develop robust models of disability progression for chronic disease. However, explicit validation is important given the complex methodological challenges faced.
format Online
Article
Text
id pubmed-4643305
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-46433052015-12-08 A longitudinal model for disease progression was developed and applied to multiple sclerosis Lawton, Michael Tilling, Kate Robertson, Neil Tremlett, Helen Zhu, Feng Harding, Katharine Oger, Joel Ben-Shlomo, Yoav J Clin Epidemiol Original Article OBJECTIVES: To develop a model of disease progression using multiple sclerosis (MS) as an exemplar. STUDY DESIGN AND SETTINGS: Two observational cohorts, the University of Wales MS (UoWMS), UK (1976), and British Columbia MS (BCMS) database, Canada (1980), with longitudinal disability data [the Expanded Disability Status Scale (EDSS)] were used; individuals potentially eligible for MS disease-modifying drugs treatments, but who were unexposed, were selected. Multilevel modeling was used to estimate the EDSS trajectory over time in one data set and validated in the other; challenges addressed included the choice and function of time axis, complex observation-level variation, adjustments for MS relapses, and autocorrelation. RESULTS: The best-fitting model for the UoWMS cohort (404 individuals, and 2,290 EDSS observations) included a nonlinear function of time since onset. Measurement error decreased over time and ad hoc methods reduced autocorrelation and the effect of relapse. Replication within the BCMS cohort (978 individuals and 7,335 EDSS observations) led to a model with similar time (years) coefficients, time [0.22 (95% confidence interval {CI}: 0.19, 0.26), 0.16 (95% CI: 0.10, 0.22)] and log time [−0.13 (95% CI: −0.39, 0.14), −0.15 (95% CI: −0.70, 0.40)] for BCMS and UoWMS, respectively. CONCLUSION: It is possible to develop robust models of disability progression for chronic disease. However, explicit validation is important given the complex methodological challenges faced. Elsevier 2015-11 /pmc/articles/PMC4643305/ /pubmed/26071892 http://dx.doi.org/10.1016/j.jclinepi.2015.05.003 Text en Crown Copyright © Published by Elsevier Inc. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Original Article
Lawton, Michael
Tilling, Kate
Robertson, Neil
Tremlett, Helen
Zhu, Feng
Harding, Katharine
Oger, Joel
Ben-Shlomo, Yoav
A longitudinal model for disease progression was developed and applied to multiple sclerosis
title A longitudinal model for disease progression was developed and applied to multiple sclerosis
title_full A longitudinal model for disease progression was developed and applied to multiple sclerosis
title_fullStr A longitudinal model for disease progression was developed and applied to multiple sclerosis
title_full_unstemmed A longitudinal model for disease progression was developed and applied to multiple sclerosis
title_short A longitudinal model for disease progression was developed and applied to multiple sclerosis
title_sort longitudinal model for disease progression was developed and applied to multiple sclerosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643305/
https://www.ncbi.nlm.nih.gov/pubmed/26071892
http://dx.doi.org/10.1016/j.jclinepi.2015.05.003
work_keys_str_mv AT lawtonmichael alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT tillingkate alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT robertsonneil alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT tremletthelen alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT zhufeng alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT hardingkatharine alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT ogerjoel alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT benshlomoyoav alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT lawtonmichael longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT tillingkate longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT robertsonneil longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT tremletthelen longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT zhufeng longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT hardingkatharine longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT ogerjoel longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis
AT benshlomoyoav longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis